Please Wait
Applying Filters...
USFDA APPLICATION NUMBER - 205626 / DOSAGE - TABLET;ORAL - 150MG;200MG;300MG
| Active Ingredient/Active Moiety | ||
| Ingredient Name | Basis of Strength | Strength |
|---|---|---|
| LAMIVUDINE(UNII: 2T8Q726O95) (LAMIVUDINE - UNII:2T8Q726O95) | LAMIVUDINE | 150mg |
| NEVIRAPINE(UNII: 99DK7FVK1H) (NEVIRAPINE - UNII:99DK7FVK1H) | NEVIRAPINE | 200mg |
| ZIDOVUDINE(UNII: 4B9XT59T7S) (ZIDOVUDINE - UNII:4B9XT59T7S) | ZIDOVUDINE | 300mg |
Inactive Ingredients
| Ingredient Name | Micro Labs Limited |
|---|---|
| CELLULOSE, MICROCRYSTALLINE(OP1R32D61U) | |
| HYPROMELLOSE 2910 (5 MPA.S)(R75537T0T4) | |
| LACTOSE MONOHYDRATE(EWQ57Q8I5X) | |
| MAGNESIUM STEARATE(70097M6I30) | |
| POLYETHYLENE GLYCOL 400(B697894SGQ) | |
| POLYSORBATE 80(6OZP39ZG8H) | |
| POVIDONE K25(K0KQV10C35) | |
| SILICON DIOXIDE(ETJ7Z6XBU4) | |
| SODIUM STARCH GLYCOLATE TYPE A POTATO(5856J3G2A2) | |
| TITANIUM DIOXIDE(15FIX9V2JP) |
